AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (19.2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Fabrication and Optimization of Febuxostat-loaded Liposomal Gel Using the Box–Behnken Design for Gout Treatment

Bhushan Rane( )Punam GadekarVaibhav PatilAkash AmkarAshish Jain
Shri D.D. Vispute College of Pharmacy and Research Center, Panvel, India
Show Author Information

Graphical Abstract

Abstract

Monosodium urate crystals form and deposit in and around the joints due to hyperuricemia, a condition characterized by a prolonged increase in serum urate levels. This leads to tissue supersaturation with urate and results in gout, a prevalent form of inflammatory arthritis. Gout can be effectively managed with febuxostat (FBT), a nonpurine selective xanthine oxidase inhibitor. Despite the efficacy of FBT, its use is limited by poor oral bioavailability and aqueous solubility, which are influenced by its co-administration with food and enzymatic degradation. To address the formulation challenges, topical liposomal formulations can be utilized. These formulations, which leverage the affinity of liposomes for keratin and their ability to penetrate deeper into the skin, offer improved drug absorption. This study aimed to develop a liposomal formulation with soy lecithin and cholesterol using the thin-film hydration method, optimized via the Box–Behnken design. The optimized liposomal formulation was then incorporated into a transdermal gel prepared with Carbopol 934 using the dispersion method. The optimized liposomal formulation demonstrated favorable properties, including a vesicle size of 392.5 ± 11.02 nm, zeta potential of 28 ± 6.13 mV, polydispersity index of 0.127, and high entrapment efficiency as confirmed via transmission electron microscopy. The resulting transdermal gel exhibited the necessary antibacterial activity; excellent stability; in vitro release of 81.33% ± 1.19% over 7 h; and appropriate pH, viscosity, spreadability, and gel strength. Overall, the liposomal gel formulation represents a highly effective approach for transdermal drug delivery.

References

[1]

M. Zishan, P. Kushwaha, K. Singh et al. An overview of: vesicular drug delivery system. World Journal of Pharmacy and Pharmaceutical Sciences, 2017, 6(5): 546−560. https://doi.org/10.20959/wjpps20175-9192

[2]

S. Talegaonkar, P.R. Mishra, R.K. Khar, et al. Vesicular systems: An overview. Indian Journal of Pharmaceutical Sciences, 2006, 68(2): 141−153. https://doi.org/10.4103/0250-474X.25707

[3]

P. Liu, G.L. Chen, J.C. Zhang. A review of liposomes as a drug delivery system: Current status of approved products, regulatory environments, and future perspectives. Molecules, 2022, 27(4): 1372. https://doi.org/10.3390/molecules27041372

[4]

J. JoshiA, R.P. Patel. Liposomes: Emerging trends in novel drug delivery with present and future challenges. International Journal of Pharmaceutical & Biological Archives, 2015, 6(2): 3−8.

[5]
S.P. Vyas, R.K. Khar. Novel carrier systems. In: Targeted and Controlled Drug Delivery (First edition). New Delhi: CBS Publishers and Distributor, 2006: 421–427.
[6]

H. Mishra, V. Chauhan, K. Kumar, et al. A comprehensive review on liposomes: A novel drug delivery system. Journal of Drug Delivery and Therapeutics, 2018, 8(6): 400−404. https://doi.org/10.22270/jddt.v8i6.2071

[7]

V. Karri, S.V. Talluri, Raviteja, et al. Formulation and evaluation of Tolnaftate loaded topical liposomal gel for effective skin drug delivery to treat fungal diseases. Journal of Chemical and Pharmaceutical Research, 2014, 6(10): 856−866.

[8]

M. Schlich, U.M. Musazzi, V. Campani, et al. Design and development of topical liposomal formulations in a regulatory perspective. Drug Delivery and Translational Research, 2022, 12(8): 1811−1828. https://doi.org/10.1007/s13346-021-01089-z

[9]

N. Sharma, S. Kumar, G. Joshi, et al. Formulation and characterization of febuxostat loaded nanostructured lipid carriers (NLCs) - gel for topical treatment of gout. Recent Patents on Nanotechnology, 2022, 16(3): 250−258. https://doi.org/10.2174/1872210515666210415114118

[10]

E. Tomba, P. Facco, F. Bezzo, et al. Latent variable modeling to assist the implementation of Quality-by-Design paradigms in pharmaceutical development and manufacturing: A review. International Journal of Pharmaceutics, 2013, 457(1): 283−297. https://doi.org/10.1016/j.ijpharm.2013.08.074

[11]

P. Shah, B. Goodyear, A. Haq, et al. Quality by design: A systematic approach using an advanced statistical tool to optimization of niosomes preparation for the topical delivery. World Journal of Pharmacy and Pharmaceutical Sciences, 2020, 9(7): 251−277.

[12]

M. Umbarkar, S. Thakare, T. Surushe, et al. Formulation and evaluation of liposome by thin film hydration method. Journal of Drug Delivery and Therapeutics, 2021, 11(1): 72−76. https://doi.org/10.22270/jddt.v11i1.4677

[13]

A. Sharma, S.L. Harikumar. Quality by design approach for development and optimization of nitrendipine loaded niosomal gel for accentuated transdermal delivery. International Journal of Applied Pharmaceutics, 2020, 12(5): 181−189. https://doi.org/10.22159/ijap.2020v12i5.38639

[14]

A.S. Alnaim, H. Shah, A.B. Nair, et al. Qbd-based approach to optimize niosomal gel of levosulpiride for transdermal drug delivery. Gels, 2023, 9(3): 213. https://doi.org/10.3390/gels9030213

[15]

Y.S. Thorat, N.S. Kote, V.V. Patil, et al. Formulation and evaluation of liposomal gel containing extract of piprine. International Journal of Current Pharmaceutical Research, 2020, 12(3): 126−129. https://doi.org/10.22159/ijcpr.2020v12i3.38321

[16]

B.A. Reddi. Why is saline so acidic (and does it really matter?). International Journal of Medical Sciences, 2013, 10(6): 747−750. https://doi.org/10.7150/ijms.5868

[17]

Y.J. Wu, B.L. Mou, S. Song, et al. Curcumin-loaded liposomes prepared from bovine milk and krill phospholipids: Effects of chemical composition on storage stability, in-vitro digestibility and anti-hyperglycemic properties. Food Research International, 2020, 136: 109301. https://doi.org/10.1016/j.foodres.2020.109301

[18]

B.V. Mitkari, S.A. Korde, K.R. Mahadik, et al. Formulation and evaluation of topical liposomal gel for fluconazole. Indian Journal of Pharmaceutical Education & Research, 2010, 44(4): 324−333

[19]

S.S. Pawar, B.R. Rane, A.S. Jain. Development and evaluation of nanoemulsion loaded metaxalone for the treatment of pain and injury. Engineering Proceedings, 2023, 56(1): 100. https://doi.org/10.3390/asec2023-15285

[20]

S.G. Amin, D.A. Shah, R.H. Dave. Formulation and evaluation of liposomes of fenofibrate prepared by thin film hydration technique. International Journal of Pharmaceutical Sciences and Research, 2018, 9(9): 3621−3637. https://doi.org/10.13040/IJPSR.0975-8232.9(9).3621-37

[21]

A.J. Amkar, B.R. Rane, A.S. Jain. Development and evaluation of nanosuspension loaded nanogel of nortriptyline HCl for brain delivery. Engineering Proceedings, 2023, 56(1): 58. https://doi.org/10.3390/asec2023-15311

[22]

K.M. Chinnala, R. Panigrahy. Formulation and evaluation of acyclovir liposomes. International Research Journal of Pharmaceutical and Biosciences, 2017, 4(1): 2394−5826.

[23]

E. Chibowski, A. Szcześ. Zeta potential and surface charge of DPPC and DOPC liposomes in the presence of PLC enzyme. Adsorption, 2016, 22(4): 755−765. https://doi.org/10.1007/s10450-016-9767-z

[24]

T.S. Telange, S.S. Pawar, A.J. Amkar, et al. Development of nanoemulsion loaded acyclovir nanogel for transdermal delivery and its evaluation. Pharmaceutical Sciences Asia, 2023, 50(4): 347−360. https://doi.org/10.0.113.162/psa.2023.04.23.616

[25]

H. Swami, A. Bilandi, M. Kataria, et al. Formulation and evaluation of liposomal gel of lornoxicam. World Journal of Pharmaceutical Research, 2015, 4(9): 2312−2338.

[26]

N.S. Kate, B.R. Rane, A.S. Jain. Development and evaluation of atorvastatin calcium nanovesicular niosomal gel for the treatment of periodontitis. Engineering Proceedings, 2023, 56(1): 66. https://doi.org/10.3390/asec2023-15313

[27]

S.S. Raut, B.R. Rane, A.S. Jain. Development and evaluation of ebastine-loaded transfersomal nanogel for the treatment of urticaria (autoimmune disease). Engineering Proceedings, 2023, 56(1): 101. https://doi.org/10.3390/asec2023-15286

[28]

R. Rane Bhushan, Y. Chavan Pushkar, S. Kate Nidhi, et al. Development of niosomal vesicles loaded mometasone furoate gel for transdermal delivery and its evaluation. Recent Advances in Drug Delivery and Formulation, 2023, 17(4): 300−313. https://doi.org/10.2174/0126673878259437231031114907

[29]

P. Deshmukh, R. Telrandhe, M. Gunde, et al. Formulation and evaluation of herbal toothpaste: compared with marketed preparation. International Journal of Pharmaceutics & Drug Analysis, 2017, 5(10): 406−410.

[30]

Q.W. Lim, J.R. Kumar. Preparation, characterization and optimization of carvedilol-β cyclodextrin liposomal based polymeric gel. Rapports De Pharmacie, 2019, 5(1): 538−548.

[31]

G.A. Abdelbary, M.H. Aburahma. Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain. Journal of Liposome Research, 2015, 25(2): 107−121. https://doi.org/10.3109/08982104.2014.941861

[32]

M.S. El-Ridy, S.A. Yehia, A.M. Mohsen, et al. Formulation of niosomal gel for enhanced transdermal lornoxicam delivery: In-vitro and In-vivo evaluation. Current Drug Delivery, 2018, 15(1): 122−133. https://doi.org/10.2174/1567201814666170224141548

[33]

N. Raytthatha, I. Shah, J. Patel, et al. Development of benzoyl peroxide loaded nanosponges gel. National Journal of Pharmaceutical Sciences, 2021, 1(2): 25−29.

[34]

S. Badvel, V.R. Tummaluru, V.R. Katta, et al. Synthesis, characterization and antimicrobial activities of amide derivatives of febuxostat intermediate. Organic Communications, 2015, 8(2): 43−51.

[35]

L.K. Vyas, K. Tapar, R. Nema, et al. Development and characterization of topical liposomal gel formulation for anti-cellulite activity. International Journal of Pharmacy and Pharmaceutical Sciences, 2013, 5(S3): 512−516.

Nano Biomedicine and Engineering
Pages 484-497
Cite this article:
Rane B, Gadekar P, Patil V, et al. Fabrication and Optimization of Febuxostat-loaded Liposomal Gel Using the Box–Behnken Design for Gout Treatment. Nano Biomedicine and Engineering, 2024, 16(3): 484-497. https://doi.org/10.26599/NBE.2024.9290095

528

Views

113

Downloads

0

Crossref

0

Scopus

Altmetrics

Received: 13 June 2024
Revised: 22 June 2024
Accepted: 08 August 2024
Published: 12 September 2024
© The Author(s) 2024.

This is an open-access article distributed under  the  terms  of  the  Creative  Commons  Attribution  4.0 International  License (CC BY) (http://creativecommons.org/licenses/by/4.0/), which  permits  unrestricted  use,  distribution,  and reproduction in any medium, provided the original author and source are credited.

Return